Comparative Analysis of Clinical Outcomes with De-escalated Versus Standard Antibiotic Therapy for Methicillin-Susceptible Staphylococcus Aureus Pneumonia in Critically Ill ICU Patients: A Multicenter Cohort Investigation - Scorecard - MDSpire

Comparative Analysis of Clinical Outcomes with De-escalated Versus Standard Antibiotic Therapy for Methicillin-Susceptible Staphylococcus Aureus Pneumonia in Critically Ill ICU Patients: A Multicenter Cohort Investigation

  • By

  • Khalid Al Sulaiman

  • Sufyan Mohammed Alomair

  • Aisha Alharbi

  • Rahaf Alqahtani

  • Asma A. Alshehri

  • Atheer O. Aldairem

  • Nada Alsuhebany

  • Khalid bin Saleh

  • Abdulaali R. Almutairi

  • Abdulmajeed A. Alzahrani

  • Manea F. Al Munjem

  • Noura H. Alotaibi

  • Rahaf A. Alnemary

  • Abdullah Musally

  • Ahmed M. Alnefaie

  • Saja Alasmari

  • Ibrahim Mahdi

  • Nadin Alanazi

  • Ahlam H. Almutairi

  • Abdullah N. Alkhuraif

  • Abdulaziz F. Alanazi

  • Wafa Al Harbi

  • Ohoud Aljuhani

  • January 16, 2026

  • 0 min

Share

Clinical Scorecard: Comparative Analysis of Clinical Outcomes with De-escalated Versus Standard Antibiotic Therapy for Methicillin-Susceptible Staphylococcus Aureus Pneumonia in Critically Ill ICU Patients: A Multicenter Cohort Investigation

At a Glance

CategoryDetail
Condition
Key MechanismsPathogenicity driven by enzymes and virulence factors like Panton-Valentine leukocidin (PVL), proteases, lipases, and hyaluronidases.
Target Population
Care Setting

Key Highlights

  • MSSA pneumonia patients have lower associated medical costs compared to MRSA patients, primarily due to avoiding costs linked to vancomycin therapy.

Guideline-Based Recommendations

Diagnosis

    Management

    • Initiate empiric anti-MRSA therapy (e.g., vancomycin or linezolid) when local MRSA prevalence exceeds 10-20%; de-escalate to β-lactam therapy upon confirmation of MSSA.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Adult patients (≥18 years) admitted to ICUs with proven MSSA respiratory cultures.

        De-escalation involves switching to narrower-spectrum agents targeting MSSA.

        Clinical Best Practices

        • Utilize MRSA nasal colonization screening to guide de-escalation, ensuring high negative predictive value (NPV) for ruling out MRSA pneumonia.

        References

        Original Source(s)

        Comparative Analysis of Clinical Outcomes with De-escalated Versus Standard Antibiotic Therapy for Methicillin-Susceptible Staphylococcus Aureus Pneumonia in Critically Ill ICU Patients: A Multicenter Cohort Investigation

        • by Khalid Al Sulaiman, Sufyan Mohammed Alomair, Aisha Alharbi, Rahaf Alqahtani, Asma A. Alshehri, Atheer O. Aldairem, Nada Alsuhebany, Khalid bin Saleh, Abdulaali R. Almutairi, Abdulmajeed A. Alzahrani, Manea F. Al Munjem, Noura H. Alotaibi, Rahaf A. Alnemary, Abdullah Musally, Ahmed M. Alnefaie, Saja Alasmari, Ibrahim Mahdi, Nadin Alanazi, Ahlam H. Almutairi, Abdullah N. Alkhuraif, Abdulaziz F. Alanazi, Wafa Al Harbi, Ohoud Aljuhani

        • January 16, 2026

        Related Content

        Early Changes in Creatinine Levels Predict Outcomes in Patients with Sepsis

        Exploratory Study of Bioactive Adrenomedullin as a Potential Biomarker for Severe Infections in Emergency Department Patients

        Compliance of procalcitonin-guided antibiotic therapy in adult infectious patients in China: a multicenter real-world retrospective study